Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Aug 6;327(2):402–410. doi: 10.1124/jpet.108.142372

Fig. 5.

Fig. 5

Regional blood flow measurement in mouse hearts during ischemia and reperfusion. Blood flow in the area at risk was measured before ischemia and during 30 min of ischemia and 60 min of reperfusion in PBS control, SODm (4 mg/kg), EUK134 (10 mg/kg), and SODm plus glibenclamide (2 mg/kg) (SODm+Glib)-treated mouse hearts. A, regional blood flow measured in PBS and SODm-treated mouse hearts. B, regional blood flow measured in EUK134 and SODm + Glib-treated mouse hearts. After SODm treatment, myocardial blood flow after reperfusion is significantly higher than that of PBS, EUK134, and SODm + Glib-treated hearts. *, p < 0.05, SODm versus PBS, EUK134, and SODm + Glib after 10 min of reperfusion, n = 7.